Mettler-Toledo International, Inc.

MTD Healthcare Diagnostics & Research

Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.48%, EPS grew 18.3%, free cash flow grew 33.0% and total debt fell 3.29%, each against the same quarter a year earlier. Member of the S&P 500.

1,622.29 16.75 −1.02%
Market cap
$32.8B
P/E
36.4×
Fwd P/E
25.5×
Dividend yield
—
F-score
5/9
Altman Z
10.23
Beneish M
−2.44
Dividend safety
n/a

Mettler-Toledo International, Inc. 10-K filed Feb 6, 2026

Fiscal year 2025 · Period ended Dec 31, 2025 · Filed · accepted 11:53 AM ET · Document on sec.gov · Filing index

What changed

Item 1, Business, against the 10-K filed Feb 7, 2025: 12 modified; 6 with only figures updated

  1. Modified · Laboratory Instruments

    We make a wide variety of precision laboratory instruments for sample preparation, synthesis, analytical bench top, material characterization, and in-line measurement. Our portfolio includes laboratory balances, liquid pipetting solutions, automated laboratory reactors including real-time analytics, titrators, pH meters, process analytics sensors and analyzer technology, physical value analyzers including density and refractometry instruments, thermal analysis systems, and other analytical instruments such as UV/VIS spectrophotometers, moisture analyzers, and cell counters. Our laboratory instruments have leading-edge embedded software and we also offer LabX, our laboratory software platform to manage and analyze data generated by our instruments and automate workflows. The laboratory instruments and related service business accounted for approximately 56% of our net sales in 2024, 55% in 20232025 and 2024, and 57compared to 55% in 20222023.

11 more changes in this Item, word by word, in Powerpack.

Powerpack